Envoy Medical, Inc. Class A Common Stock (COCH) Stock Price
COCHStock
$0.67−21.41%52W
Market Cap$51.57M
P/E—
PEG Ratio—
Div yield—
Beta2.05
COCH Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-9.51%
Price vs S&P 500 (4W)-4.66%
VGM Score25.08
COCH Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.08 | -$0.07 | +12.50%(+$0.01) | |
| Q1 2026 | -$0.14 | -$0.08 | +42.86%(+$0.06) | |
| Q3 2025 | -$0.29 | -$0.35 | -22.09%(-$0.06) | |
| Q2 2025 | -$0.29 | -$0.32 | -9.09%(-$0.03) |
COCH Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.14
4.14
4.13
4.13
Industry Peers — Orthopedic & Prosthetic Devices(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
COCHEnvoy Medical, Inc. Class A Common Stock | F | F | C | 249.8x | — | -385.5% | -11411.1% | $0.67 |
| ISRGIntuitive Surgical Inc. | D | B | B | 13.7x | 18.2% | 66.7% | 31.3% | $426.70 |
| EWEdwards Lifesciences Corp | D | C | B | 7.7x | 6.7% | 77.8% | 18.2% | $86.60 |
| STESTERIS plc | C | C | B | 3.6x | 13.8% | 44.4% | 18.9% | $222.66 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | B | 2.1x | 3.2% | 69.9% | 14.2% | $94.98 |
| SNNSmith & Nephew plc | B | C | C | 1.9x | 6.2% | 68.2% | 12.9% | $29.06 |
| ALGNAlign Technology Inc | B | D | C | 2.5x | 10.3% | 69.0% | 13.2% | $147.31 |
| MSAMine Safety Incorporated | C | C | B | 3.5x | 6.8% | 47.6% | 21.2% | $179.05 |
| ESTAEstablishment Labs Holdings Inc. | F | A | C | 7.2x | 20.0% | 70.5% | -7.6% | $59.18 |
| ENOVEnovis Corporation | B | D | C | 0.5x | -6.0% | 61.4% | -45.1% | $19.59 |
| CDRECadre Holdings, Inc. | B | C | C | 1.6x | 8.6% | 41.8% | 10.1% | $26.38 |
About Envoy Medical, Inc. Class A Common Stock
Envoy Medical Inc is a hearing health company that develops and sells the Esteem FI-AMEI implant system and replacement components. The company is dedicated to advancing hearing technology to improve patient access, usability, and quality of life.